Hematopoietic growth factors in lung cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference79 articles.
1. Systematic review and meta-analysis of randomised, phase IIIII trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced nonsmall-cell lung cancer.;Soria;Ann Oncol,2013
2. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV nonsmall-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.;Garon;Lancet,2014
3. Treating chemotherapy-induced thrombocytopenia: is it time for oncologists to use thrombopoietin agonists Oncology (Williston Park;Hassan;),2015
4. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.;Wang;Biomed Res Int,2015
5. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor.;Thomas;Curr Opin Hematol,2002
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. XRCC1, ABCB1, CYP3A5 and GSTP1 gene polymorphism associated with platinum‐based drugs induced hematotoxicity in Chinese oesophageal cancer patients;Medicine Advances;2023-06
2. Pharmacological interventions to treat adults with cancer-related fatigue;Cochrane Database of Systematic Reviews;2023-02-10
3. Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p;Frontiers in Oncology;2021-04-20
4. Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway;Frontiers in Pharmacology;2020-01-21
5. Serum ferritin and primary lung cancer;Oncotarget;2017-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3